Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3033K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wu, B. J. Articles by Stocker, R. Search for Related Content PubMed PubMed Citation Articles by Wu, B. J. Articles by Stocker, R. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections Related Article Social Bookmarking                            What's this?

¹ Centre for Vascular Research, School of Medical Sciences, University of New South Wales, and Department of Haematology, Prince of Wales Hospital, Sydney NSW 2052, Australia
² Eastern Heart Clinic, Prince of Wales Hospital, Sydney NSW 2031, Australia
³ Department of Medicine, University of Sydney, and Department of Cardiology, Royal Prince Alfred Hospital, Sydney NSW 2050, Australia
⁴ School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth WA 6001, Australia

CORRESPONDENCE Roland Stocker: r.stocker{at}unsw.edu.au

Oxidative stress is implicated in atherogenesis, yet most clinical trials with antioxidants, particularly vitamin E, have failed to protect against atherosclerotic diseases. A striking exception is probucol, which retards atherosclerosis in carotid arteries and restenosis of coronary arteries after angioplasty. Because probucol has in vitro cellular-protective effects independent of inhibiting lipid oxidation, we investigated the mode of action of probucol in vivo. We used three models of vascular disease: apolipoprotein E–deficient mice, a model of atherosclerosis; rabbit aortic balloon injury, a model of restenosis; and carotid injury in obese Zucker rats, a model of type 2 diabetes. Unexpectedly, we observed that the phenol moieties of probucol were insufficient, whereas its sulphur atoms were required for protection. Probucol and its sulphur-containing metabolite, but not a sulphur-free phenolic analogue, protected via cell-specific effects on inhibiting macrophage accumulation, stimulating reendothelialization, and inhibiting vascular smooth muscle cell proliferation. These processes were mediated via induction of heme oxygenase-1 (HO-1), an activity not shared by vitamin E. Our findings identify HO-1 as the molecular target of probucol. They indicate 2-electron rather than radical (1-electron) oxidants as important contributors to atherogenesis, and point to novel lead compounds for therapeutic intervention against atherosclerotic diseases.

K. Kathir's present address is Vascular Biology Group, ANZAC Research Institute, Concord Hospital, Concord NSW 2139, Australia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?

Jay W. Heinecke
J. Exp. Med. 2006 203: 813-816. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Wu, B. J., Midwinter, R. G., Cassano, C., Beck, K., Wang, Y., Changsiri, D., Gamble, J. R., Stocker, R. (2009). Heme Oxygenase-1 Increases Endothelial Progenitor Cells. Arterioscler. Thromb. Vasc. Bio. 29: 1537-1542 [Abstract] [Full Text]  
• Paul-Clark, M. J., McMaster, S. K., Sorrentino, R., Sriskandan, S., Bailey, L. K., Moreno, L., Ryffel, B., Quesniaux, V. F., Mitchell, J. A. (2009). Toll-like Receptor 2 Is Essential for the Sensing of Oxidants during Inflammation. Am. J. Respir. Crit. Care Med. 179: 299-306 [Abstract] [Full Text]  
• Almolki, A., Guenegou, A., Golda, S., Boyer, L., Benallaoua, M., Amara, N., Bachoual, R., Martin, C., Rannou, F., Lanone, S., Dulak, J., Burgel, P.-R., El-Benna, J., Leynaert, A. B., Aubier, M., Boczkowski, J. (2008). Heme Oxygenase-1 Prevents Airway Mucus Hypersecretion Induced by Cigarette Smoke in Rodents and Humans. Am. J. Pathol. 173: 981-992 [Abstract] [Full Text]  
• Hu, C., Dandapat, A., Sun, L., Chen, J., Marwali, M. R., Romeo, F., Sawamura, T., Mehta, J. L. (2008). LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 79: 287-293 [Abstract] [Full Text]  
• Kivela, A. M., Kansanen, E., Jyrkkanen, H.-K., Nurmi, T., Yla-Herttuala, S., Levonen, A.-L. (2008). Enterolactone Induces Heme Oxygenase-1 Expression through Nuclear Factor-E2-Related Factor 2 Activation in Endothelial Cells. J. Nutr. 138: 1263-1268 [Abstract] [Full Text]  
• Abraham, N. G., Kappas, A. (2008). Pharmacological and Clinical Aspects of Heme Oxygenase. Pharmacol. Rev. 60: 79-127 [Abstract] [Full Text]  
• Dulak, J., Deshane, J., Jozkowicz, A., Agarwal, A. (2008). Heme Oxygenase-1 and Carbon Monoxide in Vascular Pathobiology: Focus on Angiogenesis. Circulation 117: 231-241 [Abstract] [Full Text]  
• Barreiro, E., Nowinski, A., Gea, J., Sliwinski, P. (2007). Oxidative stress in the external intercostal muscles of patients with obstructive sleep apnoea. Thorax 62: 1095-1101 [Abstract] [Full Text]  
• Hill-Kapturczak, N., Agarwal, A. (2007). Haem oxygenase-1--a culprit in vascular and renal damage?. Nephrol Dial Transplant 22: 1495-1499 [Full Text]  
• Wu, B. J., Di Girolamo, N., Beck, K., Hanratty, C. G., Choy, K., Hou, J. Y., Ward, M. R., Stocker, R. (2007). Probucol [4,4'-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice. J. Pharmacol. Exp. Ther. 321: 477-484 [Abstract] [Full Text]  
• Levonen, A.-L., Inkala, M., Heikura, T., Jauhiainen, S., Jyrkkanen, H.-K., Kansanen, E., Maatta, K., Romppanen, E., Turunen, P., Rutanen, J., Yla-Herttuala, S. (2007). Nrf2 Gene Transfer Induces Antioxidant Enzymes and Suppresses Smooth Muscle Cell Growth In Vitro and Reduces Oxidative Stress in Rabbit Aorta In Vivo. Arterioscler. Thromb. Vasc. Bio. 27: 741-747 [Abstract] [Full Text]  
• Liu, X.-m., Azam, M. A., Peyton, K. J., Ensenat, D., Keswani, A. N., Wang, H., Durante, W. (2007). Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries. Cardiovasc Res 74: 169-179 [Abstract] [Full Text]  
• Stocker, R., Perrella, M. A. (2006). Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?. Circulation 114: 2178-2189 [Full Text]  
• Heinecke, J. W. (2006). Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?. JEM 203: 813-816 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS